Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain
Objective This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy. Methods SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical t...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Universidad de Navarra |
| Repositorio: | Dadun. Depósito Académico Digital de la Universidad de Navarra |
| Idioma: | inglés |
| OAI Identifier: | oai:dadun.unav.edu:10171/122073 |
| Acceso en línea: | https://hdl.handle.net/10171/122073 |
| Access Level: | acceso abierto |
| Palabra clave: | primary aldosteronism spironolactone eplerenone renin aldosterone |
| id |
ES_f7dcd7c1bbae08b1126ccfc68c3d0326 |
|---|---|
| oai_identifier_str |
oai:dadun.unav.edu:10171/122073 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain |
| title |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain |
| spellingShingle |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e primary aldosteronism spironolactone eplerenone renin aldosterone |
| title_short |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain |
| title_full |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain |
| title_fullStr |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain |
| title_full_unstemmed |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain |
| title_sort |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain |
| dc.creator.none.fl_str_mv |
Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e Paja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9 Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4 González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977ac Martín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04 Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4 García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55 Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bd Vicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513 Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77 Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40 Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbe Picón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29c Díaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccd Perdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcd Manjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0f Rebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694 Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746 María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004 Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907 Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772 Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4 Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08 Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517 Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21 Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8 Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432 Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50 Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838 Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73 Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70 Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328d Moya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9ab Gutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419 Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612 Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23 Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5 |
| author |
Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e |
| author_facet |
Goi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4e Paja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9 Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4 González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977ac Martín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04 Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4 García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55 Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bd Vicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513 Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77 Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40 Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbe Picón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29c Díaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccd Perdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcd Manjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0f Rebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694 Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746 María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004 Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907 Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772 Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4 Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08 Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517 Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21 Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8 Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432 Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50 Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838 Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73 Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70 Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328d Moya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9ab Gutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419 Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612 Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23 Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5 |
| author_role |
author |
| author2 |
Paja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9 Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4 González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977ac Martín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04 Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4 García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55 Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bd Vicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513 Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77 Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40 Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbe Picón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29c Díaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccd Perdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcd Manjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0f Rebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694 Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746 María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004 Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907 Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772 Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4 Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08 Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517 Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21 Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8 Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432 Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50 Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838 Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73 Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70 Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328d Moya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9ab Gutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419 Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612 Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23 Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5 |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Dadun. Depósito Académico Digital Universidad de Navarra |
| dc.subject.none.fl_str_mv |
primary aldosteronism spironolactone eplerenone renin aldosterone |
| topic |
primary aldosteronism spironolactone eplerenone renin aldosterone |
| description |
Objective This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy. Methods SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical treatment with mineralocorticoid receptor antagonist (MRA) as first-line or postsurgical therapy and about antihypertensive medications used before PA targeted treatment (MRA or adrenalectomy) was included. We reported surgically and medically treated patients at baseline and at last available follow-up and evaluated clinical and biochemical responses according to Primary Aldosteronism Surgical Outcome (PASO) and Primary Aldosteronism Medical treatment Outcome (PAMO) criteria. Results A total of 997 patients with PA were included. Before PA diagnosis, the classes of antihypertensive drugs most used were calcium-channel blockers (66%) and angiotensin II receptor blockers (48.4%). Of the initial cohort, 880 patients had at least 1 visit available after initiation of MRA (N = 511 as first-line therapy, N = 47 postsurgery) or adrenalectomy (N = 322). The median defined daily dose of MRA therapy was 1.33. Spironolactone was more prescribed than eplerenone (58% vs 42%). Eplerenone was better tolerated than spironolactone (AEs in 4% vs 18%), particularly among males. After a median follow-up of 35 and 17 months for medically and surgically managed patients, the latter achieved a complete biochemical (68.1%) or clinical (33.6%) response more frequently than people under MRA as first-line therapy (48.6% and 15.7%; P < .001). Conclusion This study underscores the need to optimize PA medical management in Spain to improve patient clinical and biochemical outcomes, since currently the proportion of patients achieving complete clinical and biochemical response with MRA is quite low. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 2025-01-01 2025 2025-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/10171/122073 |
| url |
https://hdl.handle.net/10171/122073 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Oxford Academic |
| publisher.none.fl_str_mv |
Oxford Academic |
| dc.source.none.fl_str_mv |
reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra instname:Universidad de Navarra |
| instname_str |
Universidad de Navarra |
| reponame_str |
Dadun. Depósito Académico Digital de la Universidad de Navarra |
| collection |
Dadun. Depósito Académico Digital de la Universidad de Navarra |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869424948366278656 |
| spelling |
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in SpainGoi, J. (Jessica)|||/items/805408b2-cc7b-4a42-96d2-1ff7afb35c4ePaja, M. (Miguel)|||/items/7363db50-6d05-4cc5-9ce0-7ef843ec77a9Rizo-Gellida, A. (Alicia)|||/items/f8a92d62-01bb-463e-87e6-0bda3a8280f4González-Boillos, M. (Marga)|||/items/14f47f15-0a8b-4767-ab55-ea0aded977acMartín-Rojas-Marcos, P. (Patricia)|||/items/2952c4f1-d2b5-421b-97f7-c957ee865b04Caja-Guayerbas, L. (Laura)|||/items/5f232a15-5671-4caf-b781-bdf334c309c4García-Cano, A.M. (Ana María)|||/items/0c1a6ede-96d1-4153-9998-690a803e2b55Ruiz-Sanchez, J.G. (Jorge Gabriel)|||/items/ef42b270-6a01-45f8-b044-f27c8fb943bdVicente, A. (Almudena)|||/items/9bcf3945-5ab8-4943-867f-7e938ff96513Gómez-Hoyos, E. (Emilia)|||/items/3b973185-2531-45e0-b301-01991f8c9b77Recasens, M. (Mónica)|||/items/b3281727-5780-40f6-ba02-7fa743c22e40Barahona-San-Millan, R. (Rebeca)|||/items/527db164-4619-4d85-b926-4b6f24c76bbePicón-César, M.J. (María José)|||/items/cc85f8bd-4d6a-4154-9926-e9d41ed8a29cDíaz-Guardiola, P. (Patricia)|||/items/958e2021-db10-4964-9ad9-e855e4626ccdPerdomo-Zelaya, C.M. (Carolina María)|||/items/4197cb06-662e-44da-bef0-348099c09dcdManjón, L. (Laura)|||/items/d15f30f7-fd73-4d9d-8b50-3f23d8a93c0fRebollo-Román, A. (Angel)|||/items/c80baf90-012b-4651-8d31-25e1356a0694Robles-Lázaro, C. (Cristina)|||/items/b1e66a15-6a19-4e31-8597-a43a0cb04746María-Recio, J. (José)|||/items/51db7c9f-2cb7-489d-b2e1-b87f7dde9004Calatayud, M. (Maria)|||/items/83518338-0d4a-4487-a5ab-04d2fe03e907Jiménez-López, N. (Noemi)|||/items/ade06492-a603-4b38-8b8a-ac36c55e4772Sampedro-Nuñez, M.A. (Miguel Antonio)|||/items/ebe0283a-614e-4b38-a4a2-b136e5f529c4Mena-Ribas, E. (Elena)|||/items/18ff8f89-b8fc-4fa2-92c9-433cf7945b08Sanmartín-Sánchez, A. (Alicia)|||/items/0e8b64e5-e76b-4dde-a559-050e69303517Gonzalvo-Diaz, C. (César)|||/items/bbc4e225-d0fd-46b9-8bc2-030587915a21Llamas-Rey, C. (Cristina)|||/items/a8ccc2ef-8b0f-4f2c-b7ea-ab12877dadb8Serrano, J. (Joaquín)|||/items/3978953f-1c47-4457-be86-a0e3d55df432Michalopoulou, T. (Theodora)|||/items/b4bc510b-e718-471b-b8f3-969c0868de50Tenés-Rodrigo, S. (Susana)|||/items/c3296936-a3ae-4b15-b255-d8b28bfb3838Pascual-Corrales, E. (Eider)|||/items/179fc326-5dc6-4a13-83a6-ea53b6cf9a73Jaén-Aguila, F. (Fernando)|||/items/11cfcb4b-ed3e-448f-a610-211dcf11dd70Muñoz-Rivas, N. (Nuria)|||/items/bd3efb7d-986d-434c-a0e0-fdbda5ba328dMoya-Mateo, E.M. (Eva María)|||/items/a2401f21-6f2d-45bb-95f2-df47cfa3a9abGutiérrez-Medina, S. (Sonsoles)|||/items/2cfa931d-4e41-4c98-9856-dc8b08a87419Hanzu, F. (Felicia)|||/items/18094f90-5b34-4f9f-a644-84baa14d7612Parra-Ramírez, P. (Paola)|||/items/5910008e-44ca-41b8-8f82-2bd8fd5c6a23Araujo-Castro, M. (Marta)|||/items/be343957-0b49-450b-9999-b8687cebeba5primary aldosteronismspironolactoneeplerenonereninaldosteroneObjective This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy. Methods SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical treatment with mineralocorticoid receptor antagonist (MRA) as first-line or postsurgical therapy and about antihypertensive medications used before PA targeted treatment (MRA or adrenalectomy) was included. We reported surgically and medically treated patients at baseline and at last available follow-up and evaluated clinical and biochemical responses according to Primary Aldosteronism Surgical Outcome (PASO) and Primary Aldosteronism Medical treatment Outcome (PAMO) criteria. Results A total of 997 patients with PA were included. Before PA diagnosis, the classes of antihypertensive drugs most used were calcium-channel blockers (66%) and angiotensin II receptor blockers (48.4%). Of the initial cohort, 880 patients had at least 1 visit available after initiation of MRA (N = 511 as first-line therapy, N = 47 postsurgery) or adrenalectomy (N = 322). The median defined daily dose of MRA therapy was 1.33. Spironolactone was more prescribed than eplerenone (58% vs 42%). Eplerenone was better tolerated than spironolactone (AEs in 4% vs 18%), particularly among males. After a median follow-up of 35 and 17 months for medically and surgically managed patients, the latter achieved a complete biochemical (68.1%) or clinical (33.6%) response more frequently than people under MRA as first-line therapy (48.6% and 15.7%; P < .001). Conclusion This study underscores the need to optimize PA medical management in Spain to improve patient clinical and biochemical outcomes, since currently the proportion of patients achieving complete clinical and biochemical response with MRA is quite low.Oxford AcademicDadun. Depósito Académico Digital Universidad de Navarra20252025-01-0120252025-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/122073reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/1220732026-06-21T12:47:57Z |
| score |
15,81155 |